首页> 美国卫生研究院文献>Translational Psychiatry >PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis
【2h】

PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis

机译:PDE4抑制增强体内海马突触可塑性并挽救MK801引起的精神病动物模型中长期增强和对象识别记忆的损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Inhibition of phosphodiesterase type 4 (PDE4) by rolipram (4-(3-(cyclopentyloxy)-4-methoxyphenyl)-pyrrolidin-2-one) has been the focus of many behavioral and molecular studies in the recent years. Rolipram exhibits memory-enhancing effects in rodents. In vitro studies have shown that long-term potentiation (LTP), which may comprise a cellular substrate for learning, is also enhanced by rolipram. However, effects have not been assessed in vivo. Rolipram has antipsychotic properties. Psychosis affects cognition and in animal models of psychosis LTP is impaired. In this study, we investigated if PDE4 inhibition improves LTP in healthy animals in vivo and if PDE4 inhibition rescues impaired LTP and prevents object recognition memory deficits in an animal model of psychosis. Recordings were made from the hippocampus of adult, freely behaving Wistar rats. Thirty minutes after treatment with rolipram or vehicle, a tetanus was applied to the medial perforant path to elicit short-term potentiation (STP) in the dentate gyrus. At this time-point, radioimmunoassay revealed that rolipram significantly elevated cyclic adenosine monophosphate levels in the dorsal hippocampus, in line with reports by others that rolipram mediates decreased PDE4 activity. In healthy animals, both intracerebroventricular and subcutaneous treatment with rolipram facilitated STP into LTP, suggesting that PDE4 inhibition may have a permissive role in plasticity mechanisms that are relevant for learning and memory. One week after a single systemic treatment with the irreversible N-methyl--aspartate antagonist, MK801, LTP and object recognition memory were significantly impaired, but could be rescued by PDE4 inhibition. These data suggest that the relief of cognitive disturbances in psychosis models by rolipram may be mediated in part by a rescue of hippocampal LTP.
机译:咯利普兰(4-(3-(环戊氧基)-4-甲氧基苯基)-吡咯烷丁-2-酮)对4型磷酸二酯酶(PDE4)的抑制是近年来许多行为和分子研究的重点。咯利普兰在啮齿动物中表现出增强记忆力的作用。体外研究表明,咯利普兰还可以增强可能包括学习细胞基质的长期增强作用(LTP)。但是,尚未在体内评估效果。咯利普兰具有抗精神病特性。精神病会影响认知,在精神病的动物模型中LTP受损。在这项研究中,我们研究了PDE4抑制作用是否能改善健康动物体内的LTP,PDE4抑制作用能否挽救受损的LTP并预防精神病动物模型中的对象识别记忆缺陷。记录是从成年海马自由行为的Wistar大鼠。用咯利普兰或溶媒治疗后三十分钟,将破伤风涂在内侧穿孔路径上,以引起齿状回的短期增强作用(STP)。在这一时间点,放射免疫分析表明,咯利普兰显着升高了海马背侧的环状单磷酸腺苷水平,这与其他人报道的咯利普兰介导的PDE4活性降低有关。在健康的动物中,使用咯利普兰进行的脑室内和皮下治疗均促进了STP转变为LTP,这表明PDE4抑制作用可能在与学习和记忆有关的可塑性机制中具有一定的作用。用不可逆的N-甲基-天冬氨酸拮抗剂单次全身治疗一周后,MK801,LTP和物体识别记忆力显着受损,但可以通过抑制PDE4来挽救。这些数据表明,咯利普兰缓解精神病模型中的认知障碍可能部分由挽救海马LTP介导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号